Anzeige
Meldung des Tages: Geologische Rarität, starke Zahlen – steht hier die Neubewertung bevor?

Trend Innovations Holding News

Aktie
WKN:  ISIN:  US89487B1008 US-Symbol:  AVAI
0,34 $
-0,02 $
-5,56%
0,29533 € 27.03.26
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

Trend Innovations Holding News

27.03.26 - PR Newswire
Scalable Biotech Manufacturing Unlocks a $14B Market
Scalable Biotech Manufacturing Unlocks a $14B Market PR Newswire
24.03.26 - PR Newswire
Anti-Aging Protein Research Takes a Step Forward with Cell Cloning
Anti-​Aging Protein Research Takes a Step Forward with Cell Cloning PR Newswire
24.03.26 - PR Newswire
Advanced Cell-based Therapy Booming the Success for Healthcare Sector
Advanced Cell-​based Therapy Booming the Success for Healthcare Sector PR Newswire
18.03.26 - PR Newswire
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. PR Newswire
03.03.26 - PR Newswire
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them PR Newswire
03.03.26 - PR Newswire
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
Investors Eye Explosive Growth in Anti-​Aging Therapies as Market Targets $420B Milestone PR Newswire
03.03.26 - PR Newswire
Avaí Bio and Austrianova Begin Production of Master Cell Bank for Klotho Anti-Aging Therapy Under GMP Standards
Avaí Bio and Austrianova Begin Production of Master Cell Bank for Klotho Anti-​Aging Therapy Under GMP Standards PR Newswire
11.02.26 - PR Newswire
Avant Technologies Completes Rebranding with Name Change to Avaí Bio and Launch of New Website
Avant Technologies Completes Rebranding with Name Change to Avaí Bio and Launch of New Website PR Newswire
29.01.26 - PR Newswire
Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration
Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration PR Newswire
26.01.26 - PR Newswire
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets PR Newswire
26.01.26 - PR Newswire
Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium
Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium PR Newswire
02.01.26 - PR Newswire
Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize
Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize PR Newswire
31.12.25 - PR Newswire
The End of Shots? 5 Biotech Stocks Rethinking Diabetes
The End of Shots? 5 Biotech Stocks Rethinking Diabetes PR Newswire
16.12.25 - PR Newswire
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy PR Newswire
16.12.25 - PR Newswire
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment PR Newswire
09.12.25 - PR Newswire
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Beyond Traditional Drugs: Novel Platforms Targeting Hard-​to-Treat Conditions PR Newswire
09.12.25 - PR Newswire
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival PR Newswire
21.10.25 - PR Newswire
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Beyond Traditional Drugs: Novel Platforms Targeting Hard-​to-Treat Conditions PR Newswire
21.10.25 - PR Newswire
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Beyond Traditional Drugs: Novel Platforms Targeting Hard-​to-Treat Conditions PR Newswire
21.10.25 - PR Newswire
Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho
Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho PR Newswire

Newssuche

Videos

newspaper
23.03.26 +6,96%
Technical Trading: Gold Long nach Absturz
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »